Inventurus Knowledge Solutions Limited (NSE:IKS)
India · Delayed Price · Currency is INR 1,527.90
+1.30 (0.09%)
Oct 24, 2025, 3:30 PM IST
NSE:IKS Revenue
Inventurus Knowledge Solutions had revenue of 7.40B INR in the quarter ending June 30, 2025, with 19.38% growth. This brings the company's revenue in the last twelve months to 27.64B, up 29.00% year-over-year. In the fiscal year ending March 31, 2025, Inventurus Knowledge Solutions had annual revenue of 26.64B with 46.54% growth.
Revenue (ttm)
27.64B
Revenue Growth
+29.00%
P/S Ratio
9.48
Revenue / Employee
3.67M
Employees
7,530
Market Cap
262.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 26.64B | 8.46B | 46.54% |
| Mar 31, 2024 | 18.18B | 7.87B | 76.28% |
| Mar 31, 2023 | 10.31B | 2.68B | 35.05% |
| Mar 31, 2022 | 7.64B | 2.11B | 38.20% |
| Mar 31, 2021 | 5.53B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Aurobindo Pharma | 320.25B |
| Cipla | 274.80B |
| Zydus Lifesciences | 236.08B |
| Apollo Hospitals Enterprise | 225.51B |
| Glenmark Pharmaceuticals | 134.56B |
| Alkem Laboratories | 133.04B |
| Mankind Pharma | 129.10B |